China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

A multi-center registration study of clinical characteristics of amyotrophic lateral sclerosis (ALS) patients with traditional Chinese medicine (TCM).

The CARE-TCM is a prospective, multi-center, patient registry study. Eligible ALS patients with TCM treatments will be enrolled in the registry. After enrollment, this research collects the individual characteristics of patients' status. Longitudinal follow-up data are collected from both patients (primary caregivers) and their treating neurologists every 3 months for 5 years. The aims of the CARE-TCM are to: 1) explore the general characteristics of ALS patients with TCM and; 2) assess the effectiveness and safety of various TCMs on ALS based on nationwide registry outcome collecting process.

Inclusion Criteria:

• Patients aged 18 years and older.
• Patients with possible, laboratory supported probable, probable, or definite ALS according to the revised El Escorial criteria.
• ALS patients treated with traditional Chinese medicine.

Exclusion Criteria:

• Patients who refuse informed consent.